BRCA2 and breast carcinoma: A major disadvantage of using this approach to identify common genetic modifiers of breast cancer, however, is the limited understanding of mechanisms and pathways that underlie breast cancer development in families carrying mutations in BRCA1 or BRCA2. An alternative and powerful approach that can overcome such issues is the use of genome-wide association (GWA) studies to identify candidate SNPs.